Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Neoplasms 5Hemorrhage 5Hematologic Neoplasms 3Head and Neck Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Recurrence 1Prostatic Neoplasms 1Postoperative Complications 1Osteosarcoma 1Myofibroma 1Metrorrhagia 1Meningioma 1Melanoma 1Leiomyoma 1Glioma 1Breast Neoplasms 1Astrocytoma 1

Interventions

Ibandronic Acid 4Zoledronic Acid 3Tranexamic Acid 2ridaforolimus 1dinutuximab 1Sodium Pertechnetate Tc 99m 1Sodium Chloride 1Neutrons 1Fluoridation 1Fibrin Tissue Adhesive 1Diathermy 1Denosumab 1Cyproheptadine 1Cefazolin 1Captopril 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Bone Neoplasms × Tranexamic Acid × Clear all
NCT04410042 2024-12-20

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

St. Jude Children's Research Hospital

Phase 3 Terminated
15 enrolled 13 charts
Sarcoma

Bone Neoplasms

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated
56 enrolled
Sarcoma

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡